Pilot study of docetaxel combined with lobaplatin or gemcitabine for recurrent and metastatic breast cancer

BACKGROUND: This study evaluated the efficacy and safety of docetaxel combined with lobaplatin, relative to docetaxel combined with gemcitabine, for treating patients with recurrent metastatic breast cancer (rMBC). METHODS: Patients with rMBC received ≥2 cycles (21 days each) of either docetaxel and...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Fenghu, Wang, Bi, He, Mingyuan, Chang, Jianying, Li, Jiehui, Shan, Lang, Wang, Heran, Hong, Wei, Luo, Daiqin, Song, Yang, Liu, Liyang, Li, Huiqin, Ran, Li, Chen, Tengxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946339/
https://www.ncbi.nlm.nih.gov/pubmed/31876741
http://dx.doi.org/10.1097/MD.0000000000018513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946339/
https://www.ncbi.nlm.nih.gov/pubmed/31876741
http://dx.doi.org/10.1097/MD.0000000000018513

Ejemplares similares